Covid-19: Key drugs, steroids in short supply; input costs surge

Two anti-virals — Remdesivir and Favipiravir — and Tocilizumab injections being used in the Covid-19 treatment have witnessed massive shortages over the last few months.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news